Navigation Links
Researchers uncover a potential new benefit of pure maple syrup on liver health
Date:9/13/2011

NEW YORK September 13, 2011 New research conducted at the University of Tokyo suggests that pure maple syrup may promote a healthy liver. The pilot study, conducted by Dr. Keiko Abe of the University of Tokyo's Graduate School of Agricultural and Life Sciences, showed that healthy laboratory rats fed a diet in which some of the carbohydrate was replaced with pure maple syrup from Canada yielded significantly better results in liver function tests than the control groups fed a diet with a syrup mix containing a similar sugar content as maple syrup. The results will be published in the November, 2011 issue of Bioscience, Biotechnology, and Biochemistry.

Although most healthy individuals take liver function for granted, liver health is of great importance because of the hundreds of vital functions it performs that are essential to human life, which include storing energy (glycogen) and regulating blood glucose, the production of certain amino acids (building blocks of protein), filtering harmful substances from the blood. Liver disease not related to alcohol consumption is estimated to affect 25% of people in the United States, according to the American Liver Foundation. It shows up most often in middle aged people who are overweight, have abnormal blood lipids and diabetes or insulin resistance conditions when grouped together, are known as metabolic syndrome.

"It is important to understand the factors leading to impaired liver function our lifestyle choices including poor diet, stress and lack of exercise, as well as exposure to environmental pollutants that produce tissue-damaging free radicals," says Dr. Melissa Palmer, clinical professor and medical director of hepatology at New York University Plainview. "The preliminary results of this research are encouraging and emphasize the importance of choosing a healthy diet to help counteract the lifestyle and environmental factors that may impact liver function, even our choice of a sweetener. In addition to Dr. Abe's recent findings, published research suggests that pure maple syrup may prove to be a better choice of sweetener because it was found to be rich in polyphenolic antioxidants and contains vitamins and minerals," notes Palmer.

Click here to view a brief video detailing the liver health findings with Dr. Keiko Abe and Dr. Melissa Palmer.

The animals were evaluated using the latest analytical methods including gene expression profiling called nutrigenomics. In the study, rats were fed diets consisting of 20% pure maple syrup, or 20% syrup mixture with similar sugar content as maple syrup. After 11 days, the rats on the maple syrup diet showed significantly decreased levels of liver enzymes AST, ALT and LDH in the blood, standard biomarkers for evaluating liver function. The gene expression profiling observations also suggest a mechanism whereby the maple syrup diet caused genes involved in the production of harmful ammonia in the liver to down-regulate, that is, to be less active.

"This research contributes to our growing understanding of the incredible health potential of maple syrup," remarked Serge Beaulieu, President of the Federation of Quebec Maple Syrup Producers. "We learned previously that maple syrup contains antioxidant compounds that may actually help regulate glucose metabolism and increase insulin release, possibly aiding in the management of type 2 diabetes. And now Dr. Abe is exploring the relationship between maple syrup consumption and liver health. Her current findings give us even more reason to enjoy our maple syrup."


'/>"/>

Contact: Laura Petrosky
lpetrosky@crt-tanaka.com
646-218-6003
CRT/tanaka
Source:Eurekalert

Related biology news :

1. EPA grants help Wayne State researchers stave off Great Lakes environmental invaders
2. UTHealth, BCM researchers find common gene variant associated with aortic dissection
3. Researchers find high levels of toxic PCBs in Indiana Harbor and Ship Canal
4. UH researchers work to develop screening method for superbug
5. Researchers find hormone that predicts premature death in kidney patients
6. Chinese researchers identify insect host species of a famous Tibetan medicinal fungus
7. Researchers publish study on neuronal RNA targeting
8. Researchers identify new drug target that stimulates
9. McMaster researchers find missing genes may separate coach potato from active cousin
10. New mutations in leukemia: Researchers found mechanism that can help design future therapies
11. Yale researchers solve mystery of disappearing bird digit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: